The cancer vaccine is still entangled in legal procedures and production capacity issues. If resolved, it could be released in three years.
According to the Russian Medical and Biological Agency, the use of antigens with altered composition in vaccines is not in accordance with current regulations. Scientists also face the problem of producing and supplying vaccines, because the country only has a few qualified facilities, such as the Blokhin Cancer Center or the Federal Center for Brain and Neurotechnology located in the United States. located in Moscow.
Mr. Vasily Lazarev, from the Russian Federal Medical and Biological Agency, said at the end of March that it may take up to a year to resolve all issues of legal procedures and by-law documents. When pressure on legality is minimized, this vaccine technology will attract domestic private investors with financial support. Thanks to that, Russia can launch a cancer vaccine within three years.
In the immediate future, the Russian Federal Agency for Health and Biology proposes to allow the production and use of drugs with modified ingredients, effective in September. This agency also requires that the production be controlled by the organization. holds the implementation patent.
The above information was released more than a month after Russian President Vladimir Putin announced that the country’s scientists were close to achieving a cancer vaccine. He did not specify what type of cancer the vaccine targets or how the vaccine works.
In the world, there are 5 potential candidates being tested, including: V940/mRNA-4157, BNT122, TG4050, Tedopi, VB10.16. Among them, the mRNA-4157 vaccine researched and developed by pharmaceutical companies Merk and Moderna has been recognized by US and European drug regulatory agencies for use in adjuvant treatment of melanoma patients. launched in 2025.
Cancer has become a constant obsession of many people and many countries. Therefore, vaccines for this disease are important immunotherapy, helping to prevent and improve cancer treatment outcomes by strengthening the body’s natural defenses.